Lilly Announces Senior Leadership Changes

INDIANAPOLIS, Feb. 11, 2011 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY)
today announced that Sue Mahony, currently senior vice president of human
resources and diversity, has been named senior vice president and president of
Lilly Oncology.

In this new role she continues to report to John Lechleiter, Ph.D., Lilly
chairman, president, and CEO, and she remains a member of the company’s
executive committee. Mahony succeeds John H. Johnson, who resigned last month.

Being promoted into Mahony’s former role is Steve Fry, currently vice president
of human resources for two of Lilly’s business areas, bio-medicines and emerging
markets. Fry now joins Lilly’s executive leadership team and reports to
Lechleiter. Both moves are effective immediately.

Mahony

“Sue brings a deep understanding of both the scientific and commercial aspects
of our business gained through a broad range of leadership roles here at Lilly
and with other major pharmaceutical companies,” said Lechleiter. “Lilly has one
of the largest clinical-stage pipelines of potential cancer medicines in the
industry. Sue is a proven leader who will help Lilly make the most of these
incredible opportunities.”

Mahony joined Lilly more than 10 years ago after a decade in sales and marketing
roles in the United Kingdom and Europe in oncology/hematology and cardiovascular
medicine for Amgen, Bristol-Myers Squibb, and Schering-Plough. She was named
general manager of Lilly Canada in 2008 after roles in global marketing and new
product development, including a leadership role in the development of
Cymbalta®. Mahony was also the Six Sigma leader for Lilly’s sales and marketing
component. She was promoted to the top human resources role in 2009.

Mahony received her bachelor’s degree and Ph.D. in pharmacy, in the Cancer
Research Campaign Experimental Chemotherapy Group, from Aston University in
Great Britain, and holds an MBA from the London Business School.

Fry

“Steve is a human resources professional who has also played a critical role in
shaping our organizational approach, including the new business areas we formed
last year. His varied experiences give him a firm grasp of how our business
operates in all parts of the world,” said Lechleiter. “Steve will build on the
momentum that Sue initiated with our diversity efforts and help ensure the
development of Lilly people remains a top priority for the company.”

Fry, who was the managing director of Lilly’s Australian affiliate from 2004 -
2007, then served in human resources capacities as executive director for the
intercontinental region and Japan until becoming vice president for
bio-medicines and emerging markets. He joined Lilly in 1987 as a scientific
systems analyst in the company’s former Greenfield, Ind. laboratories, moving
into human resources in 1992. Fry assumed a leadership role when he was selected
as the director of human resources for Lilly’s United Kingdom affiliate in 1998,
followed by executive director positions for both Lilly’s U.S. affiliate and the
pharmaceutical operations area.

Fry has a bachelor’s degree in business from the University of Indianapolis.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -
through medicines and information – for some of the world’s most urgent medical
needs. Additional information about Lilly is available at www.lilly.com.

C-LLY

SOURCE Eli Lilly and Company